Earnings History Data for Regeneron Pharmaceuticals, Inc. (REGN) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals Inc. is a biopharmaceutical company that discovers, develops, and intends to commercialize therapeutic medicines for the treatment of serious medical conditions. Regeneron has therapeutic candidates for the potential treatment of obesity, rheumatoid arthritis, cancer, and asthma and has preclinical programs in other diseases and disorders.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
02-02-2024	PM		REGN	Regeneron Pharmaceuticals, Inc.	102,710	10.18	9.10	10.96	Regeneron Pharmaceuticals beats top-line and bottom-line estimates; initiates FY24 outlook [2/2/2024 6:32 AM]	944.76	-13.02 (-1.36%)	971.00	13.22 (1.38%)	684.80 - 973.99	619,525	510,000	2,417
Regeneron Pharmaceuticals Q4 2023 Earnings Preview [2/1/2024 11:33 AM] Regeneron Pharmaceuticals beats top-line and bottom-line estimates; initiates FY24 outlook [2/2/2024 6:32 AM] Regeneron posts Q4 beat even as Eylea, COVID-19 sales dip [2/2/2024 7:13 AM] Regeneron multiple myeloma therapy accepted for EU review [2/2/2024 7:17 AM]
02-11-2023	PM		REGN	Regeneron Pharmaceuticals, Inc.	84,660	10.17	9.39	9.98	Regeneron Pharmaceuticals beats Q3 top and bottom line estimates; updates FY23 outlook [11/2/2023 6:32 AM]	818.79	27.52 (3.48%)	818.79	0.0 (0.00%)	668.00 - 853.97	697,326	440,000	21,907
Regeneron Pharmaceuticals Q3 2023 Earnings Preview [11/1/2023 12:43 PM] Regeneron Pharmaceuticals beats Q3 top and bottom line estimates; updates FY23 outlook [11/2/2023 6:32 AM] Regeneron Q3 sales drop as Eylea underperforms [11/2/2023 8:02 AM]
03-08-2023	PM		REGN	Regeneron Pharmaceuticals, Inc.	81,080	8.79	8.48	9.77	Regeneron Pharmaceuticals Non-GAAP EPS of $10.24 beats by $0.34, revenue of $3.16B beats by $140M [8/3/2023 6:31 AM]	771.45	39.33 (5.37%)	771.45	0.0 (0.00%)	572.22 - 837.55	1,019,923	690,000	7,313
Regeneron Pharmaceuticals Q2 2023 Earnings Preview [8/2/2023 11:58 AM] Regeneron Pharmaceuticals Non-GAAP EPS of $10.24 beats by $0.34, revenue of $3.16B beats by $140M [8/3/2023 6:31 AM] Regeneron gains after Q2 beat; FDA action on high-dose Eylea expected in Q3 [8/3/2023 8:00 AM]
04-05-2023	PM	6:30 AM ET (May 4)	REGN	Regeneron Pharmaceuticals, Inc.	87,600	8.44	7.71	11.49	Regeneron Pharmaceuticals Non-GAAP EPS of $10.09 beats by $0.53, revenue of $3.16B beats by $160M [5/4/2023 6:32 AM]	754.56	-48.61 (-6.05%)	772.05	-31.12 (-3.87%)	538.01 - 837.55	1,083,477	540,000	12,165
Regeneron looks to strong Dupixent, Eylea sales in Q1 report [5/3/2023 1:59 PM] Regeneron Pharmaceuticals Q1 2023 Earnings Preview [5/3/2023 1:37 PM] Regeneron Pharmaceuticals Non-GAAP EPS of $10.09 beats by $0.53, revenue of $3.16B beats by $160M [5/4/2023 6:32 AM] Regeneron stock dips amid decline in Eylea sales despite Q1 beat [5/4/2023 7:29 AM]
03-02-2023	PM	6:30 AM ET (Feb 3)	REGN	Regeneron Pharmaceuticals, Inc.	82,550	10.96	8.18	23.72	Regeneron Pharmaceuticals reports Q4 earnings beat; initiates FY23 guidance [2/3/2023 6:34 AM]	784.13	32.93 (4.38%)	765.43	14.23 (1.89%)	538.01 - 789.95	1,188,161	620,000	2,129
All eyes on Regeneron Q4 results with focus on blockbusters Dupixent, Eylea [2/2/2023 11:31 AM] Sanofi stock dips as Q4 revenue grows but vaccine sales fall; Dupixent drives moderate profit outlook [2/3/2023 5:13 AM] Regeneron Pharmaceuticals reports Q4 earnings beat; initiates FY23 guidance [2/3/2023 6:34 AM] Regeneron posts Q4 beat as COVID therapy offsets Eylea impact [2/3/2023 7:28 AM]
03-11-2022	PM	6:30 AM ET (Nov 3)	REGN	Regeneron Pharmaceuticals, Inc.	82,840	9.98	8.55	15.37	Regeneron Pharmaceuticals Non-GAAP EPS of $11.14 beats by $1.52, revenue of $2.94B beats by $80M [11/3/2022 6:31 AM]	739.68	-0.80 (-0.11%)	734.00	-6.48 (-0.88%)	538.01 - 764.59	627,643	710,000	703
Can Regeneron maintain EPS beat run in Q3 as eye care space heats up? [11/2/2022 2:15 PM] Regeneron Pharmaceuticals Non-GAAP EPS of $11.14 beats by $1.52, revenue of $2.94B beats by $80M [11/3/2022 6:31 AM] Regeneron Q3 sales sans COVID products grow on back of blockbuster Eylea [11/3/2022 7:12 AM] Regeneron Presents New Data at ASH from Advancing Hematology Pipeline across Multiple Blood Cancers and Disorders [Nov-03-22 09:00AM] Regeneron Pharmaceuticals Tops Quarterly Expectations Despite Covid Shortfall [Nov-03-22 08:52AM] Regeneron (REGN) Surpasses Q3 Earnings and Revenue Estimates [Nov-03-22 08:05AM] Regeneron Pharmaceuticals Q3 tops earnings and revenue marks [Nov-03-22 06:51AM] Regeneron Reports Third Quarter 2022 Financial and Operating Results [Nov-03-22 06:30AM] Drug, Biotech Stocks' Q3 Earnings on Nov 3: AMGN, REGN & More [Nov-02-22 09:25AM] Are Investors Undervaluing Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) By 29%? [Nov-02-22 09:00AM] Regeneron Sinks Despite Massive Earnings Beat On A Notable Blockbuster Miss [Nov-03-22 10:06AM]
03-08-2022	PM	6:30 AM ET (Aug 3)	REGN	Regeneron Pharmaceuticals, Inc.	64,380	9.77	8.53	27.97	Regeneron Pharmaceuticals Non-GAAP EPS of $9.77 beats by $1.02, revenue of $2.86B beats by $60M [8/3/2022 6:34 AM]	608.64	33.68 (5.86%)	589.00	14.04 (2.44%)	538.01 - 747.42	853,979	540,000	108,898
Eyes on sales of blockbuster drugs Eylea, Dupixent for Regeneron's Q2 2022 earnings [8/2/2022 12:20 PM] Regeneron Pharmaceuticals Non-GAAP EPS of $9.77 beats by $1.02, revenue of $2.86B beats by $60M [8/3/2022 6:34 AM] Regeneron posts 2Q revenue drop as sales of COVID-19 therapy plummet [8/3/2022 7:44 AM] Novel Costimulatory Bispecific Antibody Shows Encouraging Anti-tumor Activity When Combined with PD-1 Inhibitor Libtayo® (cemiplimab) in Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC) [Aug-03-22 06:25AM] Regeneron Pharmaceutical Beats Second-Quarter Views But Logs No Covid Sales [Aug-03-22 09:03AM] Regeneron tops earnings expectations amid 'record' sales of several products [Aug-03-22 06:58AM] UPDATE 3-Regeneron beats sales estimates on strong demand for blockbuster eye drug [Aug-03-22 06:39AM] Regeneron beats sales estimates on strong demand for blockbuster eye drug [Aug-03-22 06:36AM] Regeneron Reports Second Quarter 2022 Financial and Operating Results [Aug-03-22 06:30AM]
04-05-2022	PM	6:30 AM ET (May 4)	REGN	Regeneron Pharmaceuticals	71,539	11.49	9.37	0.00	Regeneron Pharmaceuticals Non-GAAP EPS of $11.49 beats by $1.69, revenue of $2.97B beats by $280M [5/4/2022 6:33 AM]	660.49	0.0 (0.00%)	675.00	14.51 (2.20%)	478.40 - 747.42	796,036	550,000	8,377
All eyes on Regeneron Q1 earnings amid REGEN-COV, Eylea challenges [5/3/2022 1:10 PM] Regeneron Pharmaceuticals Non-GAAP EPS of $11.49 beats by $1.69, revenue of $2.97B beats by $280M [5/4/2022 6:33 AM] Regeneron Q1 revenue rises on the back of blockbuster drugs Eylea, Dupixent [5/4/2022 7:35 AM] Dow Jones Futures: New Market Rally Awaits Fed Decision; AMD, Lithium Play Livent Jump Late [May-03-22 08:20PM] Regeneron Reports First Quarter 2022 Financial and Operating Results [May-04-22 06:30AM] UPDATE 1-Regeneron quarterly profit drops as COVID antibody sales hit [May-04-22 06:50AM] Regeneron shares up 1.4% premarket after earnings top estimates [May-04-22 06:47AM] Regeneron Stock Rises as First-Quarter Earnings Top Forecasts [May-04-22 07:16AM] UPDATE 2-Regeneron quarterly profit drops as COVID antibody sales hit [May-04-22 06:50AM] Regeneron quarterly profit drops as COVID antibody sales hit [May-04-22 06:41AM] Dow Jones Futures Climb Ahead Of Fed Rate Hike Decision; AMD Surges On Earnings [May-04-22 08:31AM] How Regeneron Pharmaceuticals Beat Quarterly Projections Without Leaning On Covid [May-04-22 09:13AM] Regeneron's COVID drug sales outside U.S. help revenue beat [May-04-22 06:41AM] Dow Jones Climbs Ahead Of Fed Rate Hike Decision; AMD Surges On Earnings [May-04-22 09:31AM] Regeneron (REGN) Q1 Earnings and Revenues Beat Estimates [May-04-22 07:45AM] UPDATE 3-Regeneron's COVID drug sales outside U.S. help revenue beat [May-04-22 06:50AM] Regenerons First-Quarter Earnings Top Forecasts but the Stock Trades Lower [May-04-22 11:22AM] Why The First Quarter Could Be A 'High-Water Mark' For Regeneron [May-04-22 12:01PM] Regeneron (REGN) Q1 Earnings Beat, COVID Antibody Sales Affected [May-04-22 11:54AM] CORRECTED-UPDATE 3-Regeneron's COVID drug sales outside U.S. help revenue beat [May-04-22 06:50AM]
04-02-2022	PM	6:30 AM ET (Feb 4)	REGN	Regeneron Pharmaceuticals, Inc.	66,980	23.72	18.49	8.72	Regeneron Pharmaceuticals Non-GAAP EPS of $23.72 beats by $3.67, revenue of $4.95B beats by $460M [2/4/2022 6:31 AM]	623.43	2.74 (0.44%)	615.00	-5.69 (-0.92%)	441.00 - 686.62	1,077,374	930,000	9,669
Can Regeneron Pharma top Q4 earnings forecast amid COVID challenges? [2/3/2022 9:12 AM] Regeneron Pharmaceuticals Non-GAAP EPS of $23.72 beats by $3.67, revenue of $4.95B beats by $460M [2/4/2022 6:31 AM] Regeneron more than doubles Q4 revenue powered by sales for COVID-19 antibody [2/4/2022 8:03 AM] 10 Biotech Stocks to Buy According to Matthew Strobecks Birchview Capital [Feb-03-22 02:36PM] Appleton Partners Inc Buys Alexandria Real Estate Equities Inc, Global X The Global X Video ... [Feb-03-22 01:38PM] Pacer Advisors, Inc. Buys LyondellBasell Industries NV, CVS Health Corp, Dow Inc, Sells , ... [Feb-03-22 01:38PM] Why Regeneron (REGN) Might Surprise This Earnings Season [Feb-03-22 08:32AM] Regeneron Reports Fourth Quarter and Full Year 2021 Financial and Operating Results [Feb-04-22 06:30AM] Regeneron shares up premarket after Q4 revenue doubles and blows past estimates [Feb-04-22 06:41AM] Dow Jones Futures Fall Ahead Of Jobs Report; Amazon Soars, But Ford Dives On Earnings [Feb-04-22 08:08AM] Dow Jones Futures Slide As Yields Surge On Jobs Report; Amazon Soars, But Ford Dives On Earnings [Feb-04-22 08:37AM] Regeneron Stock Fell Despite Strong Earnings. This Is Why. [Feb-04-22 09:18AM] Regeneron Scores Quarterly Beat On Covid Cocktail But Future Sales Are Shaky [Feb-04-22 09:16AM] Dow Jones Falls As Yields Surge On Jobs Report; Amazon Soars, But Ford Dives On Earnings [Feb-04-22 09:32AM] Regeneron (REGN) Q4 Earnings and Revenues Top Estimates [Feb-04-22 08:05AM] Four drug makers raked in $14 billion in sales of COVID-19 treatments in 2021. How will they do this year? [Feb-04-22 10:12AM] This Will Put a Big Dent in Eli Lilly's and Regeneron's Sales This Year [Feb-04-22 11:00AM] Regeneron's Q4 Sales, Profits More Than Double With Boost From COVID-19 Treatment Sales [Feb-04-22 08:01AM] Sanofi CFO details earnings, COVID-19 vaccine outlook, and drug development [Feb-04-22 11:46AM] Regeneron (REGN) Beats on Q4 Earnings, Gains on REGEN-COV [Feb-04-22 10:20AM] Sanofi (SNY) Q4 Earnings Beat, Vaccines Hurt Sales Growth [Feb-04-22 10:03AM] Regeneron Scores Quarterly Beat But How Long Will Its Covid Tailwind Persist? [Feb-04-22 12:22PM] Stocks Drop as Jobs Report Increases Rate-Hike Jitters [Feb-04-22 12:05PM] Kodiak (KOD) Completes Enrolling Patients in Retina-Based Studies [Feb-04-22 11:55AM] Cowa, Llc Buys Avantis U.S. Small Cap Value ETF, Dimensional International Core Equity Market ... [Feb-04-22 05:38PM]
04-11-2021	PM	6:30 AM ET (Nov 4)	REGN	Regeneron Pharmaceuticals, Inc.	68,360	15.37	9.81	7.68	Regeneron Pharmaceuticals EPS beats by $5.43, beats on revenue [11/4/2021 6:33 AM]	647.63	-4.47 (-0.69%)	647.63	0.0 (0.00%)	441.00 - 686.62	1,451,350	770,000	10,704
Will Regeneron Pharmaceuticals maintain EPS beat run in Q3? [11/3/2021 12:16 PM] Regeneron Pharmaceuticals EPS beats by $5.43, beats on revenue [11/4/2021 6:33 AM] Regeneron posts Q3 beat powered by EYLEA and Dupixent [11/4/2021 7:07 AM] COVID-19 vaccine has an incredibly positive benefit to risk ratio: Doctor [Nov-03-21 05:35PM] 10 Best Cancer Stocks To Buy Now [Nov-03-21 03:25PM] Is Regeneron Pharmaceuticals (REGN) Outperforming Other Medical Stocks This Year? [Nov-03-21 11:30AM] Drug, Biotech Stock Q3 Earnings on Nov 4: MRNA, REGN & More [Nov-03-21 11:04AM] Should You Buy Regeneron Pharmaceuticals (REGN) Ahead of Earnings? [Nov-03-21 10:57AM] Bausch's (BHC) Q3 Earnings Beat Estimates, Revenues Miss [Nov-03-21 09:20AM] Regeneron Reports Third Quarter 2021 Financial and Operating Results [Nov-04-21 06:30AM] Regeneron earnings boosted by $804 million in sales of COVID antibody treatment [Nov-04-21 06:46AM] Regeneron beats quarterly sales on COVID-19 drug demand [Nov-04-21 06:42AM] Moderna Slumps Premarket; Regeneron and Qualcomm Rise [Nov-04-21 03:57AM] How Regeneron's Covid Drug Lent Itself To A Big Third-Quarter Beat [Nov-04-21 09:06AM] Regeneron Presentations at ASH Highlight Expanding Clinical Research in Blood Cancers and Disorders [Nov-04-21 10:00AM] Regeneron Earnings Blow Past Estimates on Strong Covid-19 Antibody Sales [Nov-04-21 09:53AM] Regeneron (REGN) Tops Q3 Earnings and Revenue Estimates [Nov-04-21 07:55AM] Regeneron Results Beat Estimates; U.S. Buys More Antibody Treatment [Nov-04-21 06:24AM] Zacks Earnings ESP: A Better Way to Find Earnings Surprises for Medical [Nov-04-21 08:50AM] Why Regeneron Shares Are Rising Today [Nov-04-21 09:24AM] Regeneron (REGN) Q3 Earnings Beat, REGEN-COV Boosts Growth [Nov-04-21 11:48AM] Bluebird bio completes spinout of oncology business 2seventy bio [Nov-04-21 04:35PM]
05-08-2021	PM	6:30 AM ET (Aug 5)	REGN	Regeneron Pharmaceuticals, Inc.	62,490	27.97	9.12	6.29	Regeneron Pharmaceuticals EPS beats by $8.09, beats on revenue [8/5/2021 6:33 AM]	602.33	21.38 (3.68%)	587.00	6.05 (1.04%)	441.00 - 660.00	1,501,260	550,000	22,300
Regeneron Pharmaceuticals Q2 2021 Earnings Preview [8/4/2021 2:11 PM] Regeneron/Sanofi stops late-stage Libtayo study early after improvement in survival in NSCLC patients [8/5/2021 6:23 AM] Regeneron Pharmaceuticals EPS beats by $8.09, beats on revenue [8/5/2021 6:33 AM] Regeneron shares rise on Q2 earnings beat, FY forecast [8/5/2021 6:54 AM] New England Journal of Medicine Publishes Positive Phase 3 Trial Results for REGEN-COV (casirivimab and imdevimab) to Prevent SARS-CoV-2 Infection [Aug-04-21 05:05PM] Should the Lambda Variant Worry You? Not if Youre Vaccinated. [Aug-04-21 01:18PM] Drug/Biotech Stocks Q2 Earnings Due on Aug 5: REGN, MRNA, ZTS, ILMN [Aug-04-21 10:39AM] Roche Gains as Softbank Builds $5 Billion Stake [Aug-04-21 01:48AM] 3 Biotech Stocks That Could Make You Richer in August (and Beyond) [Aug-05-21 06:02AM] Phase 3 Trial of Libtayo® (cemiplimab-rwlc) Combined with Chemotherapy Stopped Early Due to Significant Improvement in Overall Survival in Patients with First-line Advanced Non-small Cell Lung Cancer [Aug-05-21 06:00AM] Regeneron Reports Second Quarter 2021 Financial and Operating Results [Aug-05-21 06:30AM] Regeneron quarterly profit surges on COVID-19 antibody cocktail demand [Aug-05-21 06:53AM] UPDATE 1-Regeneron quarterly profit surges on COVID-19 antibody cocktail demand [Aug-05-21 06:49AM] Regeneron shares jump 3.3% premarket after earnings blow past estimates; COVID antibody sales total $2.59 billion [Aug-05-21 06:55AM] Regeneron Earnings Obliterate Views; Biotech Giant Tops Buy Point [Aug-05-21 07:12AM] Regeneron results beat estimates on COVID-19 therapy boost [Aug-05-21 06:53AM] Regeneron Earnings Top Estimates. Its Stock May Be Breaking Out. [Aug-05-21 07:44AM] Regeneron (REGN) Q2 Earnings and Revenues Top Estimates [Aug-05-21 07:45AM] 10 Best Biotech Stocks to Buy According to Alan Fraziers Frazier Healthcare Partners [Aug-05-21 10:50AM] Initial Jobless Claims Decline, BOE Keeps Policy Unchanged [Aug-05-21 10:19AM] Regeneron (REGN) Q2 Earnings Beat, REGEN-COV Boosts Performance [Aug-05-21 10:09AM] Regeneron sees uptick in COVID-19 therapy use as cases rise [Aug-05-21 06:53AM] Regeneron Stock Flirts With Breakout As Covid Drug Beats Views By $1 Billion [Aug-05-21 12:32PM] Weekly Jobless Claims Decline [Aug-05-21 11:10AM] Doctor on booster shots: People shouldnt be so anxious to get another shot [Aug-05-21 01:47PM] Regeneron Pharmaceuticals Inc (REGN) Q2 2021 Earnings Call Transcript [Aug-05-21 03:31PM] Coronavirus vaccine: More people vaccinated is more important than boosters, doctor says [Aug-05-21 01:47PM]
06-05-2021	PM	6:30 AM ET (May 6)	REGN	Regeneron Pharmaceuticals, Inc.	51,680	10.09	7.78	5.87	Regeneron Pharmaceuticals EPS beats by $1.19, misses on revenue [5/6/2021 6:31 AM]	498.68	16.26 (3.37%)	498.68	0.0 (0.00%)	441.00 - 664.64	1,525,703	740,000	6,225
Regeneron Pharmaceuticals EPS beats by $1.19, misses on revenue [5/6/2021 6:31 AM] Regeneron Pharma off to a strong start in 2021 with double-digit top and bottom-line growth; U.S. REGEN-COV sales of $262.2M [5/6/2021 7:15 AM] Former Acting CDC Director on why it's 'really important' to pay attention to COVID-19 variants [May-05-21 02:06PM] Zacks Earnings ESP: A Better Way to Find Earnings Surprises for Medical [May-05-21 10:01AM] India Gives Emergency Use Nod To Roche-Regeneron's COVID-19 Antibody Cocktail [May-05-21 09:19AM] UPDATE 1-India approves Roche/Regeneron antibody cocktail to treat COVID-19 [May-05-21 09:01AM] Should You Buy Regeneron (REGN) Ahead of Earnings? [May-05-21 08:44AM] Regeneron Reports First Quarter 2021 Financial and Operating Results [May-06-21 06:30AM] UPDATE 1-Regeneron quarterly profit rises 78% on Eylea strength [May-06-21 06:44AM] Regeneron quarterly profit rises 78% on Eylea strength [May-06-21 06:39AM] Regeneron Pharmaceuticals, Inc. to Host Earnings Call [May-06-21 06:30AM] Regeneron Earnings Top, Biotech Giant Edges Higher [May-06-21 06:48AM] Regeneron stock rises, as profit, revenue and sales of SARS-CoV-2 antibody cocktail beat expectations [May-06-21 06:43AM] Regeneron's COVID-19 therapy helps boost quarterly profit [May-06-21 06:39AM] UPDATE 2-Regeneron's COVID-19 therapy helps boost quarterly profit [May-06-21 06:44AM] Regeneron Earnings Lift Stock. Heres Why. [May-06-21 07:34AM] Regeneron (REGN) Tops Q1 Earnings Estimates [May-06-21 07:45AM] US STOCKS-Futures flat after jobless claims data; drugmakers extend fall [May-06-21 09:09AM] US STOCKS-Nasdaq, S&P 500 slip as COVID-19 vaccine makers fall [May-06-21 10:20AM] Why Regeneron's Q1 Results Looked Great Despite Its Revenue Miss [May-06-21 10:47AM] Regeneron Edges Higher After Covid Treatment Beats First-Quarter Views [May-06-21 11:06AM] UPDATE 3-Regeneron expects continuing demand for its COVID-19 therapy [May-06-21 06:44AM] Regeneron expects continuing demand for its COVID-19 therapy [May-06-21 06:39AM] Regeneron Reports Mixed Bag On Q1 Earnings; Eylea Franchise Boosts Revenue [May-06-21 09:10AM] US STOCKS-Dow hits record high as cyclicals rise on jobless claims data [May-06-21 12:48PM] U.S. backing waiver of patent protection for vaccines is a complex issue: Doctor [May-06-21 01:54PM] Regeneron (REGN) Q1 Earnings Beat on Strong Eylea & Dupixent [May-06-21 01:20PM] Regeneron Pharmaceuticals Inc (REGN) Q1 2021 Earnings Call Transcript [May-06-21 03:30PM] Regeneron Pops After Covid Treatment Beats First-Quarter Views [May-06-21 04:38PM] US STOCKS-Dow ends at record high after upbeat jobless claims report [May-06-21 04:22PM] US STOCKS-Dow closes at record high after upbeat jobless claims report [May-06-21 04:00PM]
05-02-2021	PM	6:30 AM ET (Feb 5)	REGN	Regeneron Pharmaceuticals, Inc.	53,350	8.72	7.11	6.58	Regeneron Pharmaceuticals EPS beats by $1.24, beats on revenue [2/5/2021 6:32 AM]	498.63	-0.21 (-0.04%)	513.48	14.64 (2.93%)	363.00 - 664.64	1,425,903	1,037,122	61,263
Regeneron Pharmaceuticals EPS beats by $1.24, beats on revenue [2/5/2021 6:32 AM] Regeneron Pharmaceuticals Q4 2020 Earnings Preview [2/4/2021 12:58 PM] Regeneron Pharma posts double-digit top and bottom-line growth, shares up 3% [2/5/2021 7:01 AM] Regeneron (REGN) Q4 Earnings, Sales Beat on Solid Dupixent Show [Feb-05-21 10:54AM] Regeneron Pharmaceuticals Tops Profit Estimates; Stock Has Over 30% Upside Potential [Feb-05-21 10:16AM] Regeneron's COVID-19 antibody drug generated $145 million in sales in Q4 [Feb-05-21 07:55AM] Regeneron's stock rallies after profit rises well above expectations, while revenue matches [Feb-05-21 06:46AM] Regeneron Reports Fourth Quarter and Full Year 2020 Financial and Operating Results [Feb-05-21 06:30AM] Regeneron Pharmaceuticals, Inc. to Host Earnings Call [Feb-05-21 06:30AM] Regeneron Profit Beats After Covid Drug Cleared for Use [Feb-05-21 03:35AM] Twist Bioscience Corp (TWST) Q1 2021 Earnings Call Transcript [Feb-05-21 12:01AM] Sanofi to expand cost-savings push as earnings beat expectations [Feb-04-21 07:00PM] Regeneron Pharmaceuticals's Earnings Outlook [Feb-04-21 11:30AM]
05-11-2020	PM	6:30 AM ET (Nov 5)	REGN	Regeneron Pharmaceuticals, Inc.	59,280	7.68	9.52	5.84	Regeneron Pharmaceuticals EPS beats by $1.37, beats on revenue [11/5/2020 6:32 AM]	588.81	1.67 (0.28%)	588.81	0.0 (0.00%)	322.11 - 664.64	900,627	727,996	16,939

05-08-2020	PM	6:30 AM ET (Aug 5)	REGN	Regeneron Pharmaceuticals, Inc.	64,850	6.29	5.59	5.29	Regeneron Pharmaceuticals EPS beats by $1.20, beats on revenue [8/5/2020 6:32 AM]	636.32	-12.11 (-1.87%)	655.00	6.57 (1.01%)	271.37 - 664.64	498,556	646,962	11,776

05-05-2020	PM	6:30 AM ET (May 5)	REGN	Regeneron Pharmaceuticals, Inc.	59,130	5.87	4.89	3.75	Regeneron Pharmaceuticals EPS beats by $0.51, beats on revenue [5/5/2020 6:32 AM]	573.22	31.40 (5.80%)	563.00	21.18 (3.91%)	271.37 - 581.00	686,644	963,756	20,664